Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

NCT00205907 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Change in Formulation

Conditions

Pulmonary Emphysema

Interventions

BIOLOGICAL: BLVR Hydrogel

Sponsor

Aeris Therapeutics